- Presentations
- 5
- Markets
- 1
Tyenne is a brand of Tocilizumab marketed by Fresenius Kabi, with 5 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Tocilizumab
- Brand owner
- Fresenius Kabi
- Registered in
- United States
- Strengths and forms
- 162 mg/0.9 mL injection, 200 mg/10 mL injection, 400 mg/20 mL injection, 80 mg/4 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tyenne 162 mg/0.9 mL injectionSubcutaneous Cold chain | Fresenius Kabi | US FDA | Available on request |
| Tyenne 162 mg/0.9 mL injectionSubcutaneous Cold chain | Fresenius Kabi | US FDA | Available on request |
| Tyenne 200 mg/10 mL injectionIntravenous Cold chain | Fresenius Kabi | US FDA | Available on request |
| Tyenne 400 mg/20 mL injectionIntravenous Cold chain | Fresenius Kabi | US FDA | Available on request |
| Tyenne 80 mg/4 mL injectionIntravenous Cold chain | Fresenius Kabi | US FDA | Available on request |
Equivalent brands
Other brands of Tocilizumab.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Tyenne
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.